Nonalcoholic steatohepatitis [dsyn]    
Cost Analysis [ocac]    
Utilities [orgt]    
Nonalcoholic steatohepatitis [dsyn]    
Common [qnco]    
Liver disease [dsyn]    
Developed Countries [qlco]    
Current [tmco]    
Data [idcn]    
Cost Effectiveness [qnco]    
Therapeutic [topp]    
Option [ftcn]    
Life Style [socb]    
Modification [ftcn]    
Cost Analysis [ocac]    
Utilities [orgt]    
Compare [acty]    
strategies [menp]    
Using [ftcn]    
Third Party Payer [hcro]    
Determinant [idcn]    
Model [inpr]    
To [qlco]    
Compare [acty]    
Cost [qnco]    
Health [idcn]    
Benefit [qnco]    
Life Style [socb]    
Modification [ftcn]    
Alone [qnco]    
Cohort [popg]    
patient [podg]    
Age [orga]    
year [tmco]    
biopsied [diap]    
Proven [qlco]    
Nonalcoholic steatohepatitis [dsyn]    
Fibrosis [patf]    
Level 3 [inpr]    
greater [qnco]    
Assumed [inpr]    
Annual [tmco]    
Cycle [tmco]    
Length [qnco]    
Probabilities [qnco]    
Utilities [orgt]    
Estimate [qnco]    
derivation [qlco]    
Review, Systematic [inpr]    
Literature [inpr]    
uncertainties [idcn]    
Parameter [spco]    
Estimate [qnco]    
Test [inpr]    
Using [ftcn]    
One [qnco]    
Two [qnco]    
Sensitive [qnco]    
Analysis [lbpr]    
outcome measure [qnco]    
Increment [qnco]    
Cost Effectiveness [qnco]    
Ratio [qnco]    
less [inpr]    
consider [idcn]    
Cost Effectiveness [qnco]    
Comparison [acty]    
Life Style [socb]    
Modification [ftcn]    
Alone [qnco]    
treatment [ftcn]    
Life Style [socb]    
Modification [ftcn]    
Cost Effectiveness [qnco]    
Increment [qnco]    
Cost Effectiveness [qnco]    
Ratio [qnco]    
Year, Quality-Adjusted Life [tmco]    
Gain [qnco]    
Direct [qlco]    
Comparison [acty]    
More [ftcn]    
Cost Effectiveness [qnco]    
Increment [qnco]    
Cost Effectiveness [qnco]    
Ratio [qnco]    
Year, Quality-Adjusted Life [tmco]    
Gain [qnco]    
Sensitive [qnco]    
Analysis [lbpr]    
Indicated [fndg]    
Not [ftcn]    
Cost Effectiveness [qnco]    
% total [qnco]    
Drug Cost [qnco]    
greater [qnco]    
A16 [inpr]    
Per Annum [tmco]    
Annual [tmco]    
Probabilities [qnco]    
Cirrhosis [dsyn]    
Advance [qlco]    
Fibrosis [patf]    
less [inpr]    
+2 [qnco]    
Conclusion [idcn]    
Model [inpr]    
Analysis [lbpr]    
Suggest [idcn]    
patient [podg]    
Advance [qlco]    
Fibrosis [patf]    
Nonalcoholic steatohepatitis [dsyn]    
Pharmacological Treatment [topp]    
Standard [qlco]    
Life Style [socb]    
Modification [ftcn]    
Likely [qlco]    
Cost Effectiveness [qnco]    
Hepatology [bmod]    
